Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · Real-Time Price · USD
0.6490
-0.0010 (-0.15%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Check-Cap Market Cap
Check-Cap has a market cap or net worth of $3.91 million as of April 24, 2025. Its market cap has decreased by -74.26% in one year.
Market Cap
3.91M
Enterprise Value
-13.91M
1-Year Change
-74.26%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since March 4, 2015, Check-Cap's market cap has decreased from $33.40M to $3.91M, a decrease of -88.29%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 3.80M | -34.48% |
| Dec 31, 2024 | 5.80M | -52.46% |
| Dec 29, 2023 | 12.20M | -4.69% |
| Dec 30, 2022 | 12.80M | -80.31% |
| Dec 31, 2021 | 65.00M | 205.16% |
| Dec 31, 2020 | 21.30M | 131.52% |
| Dec 31, 2019 | 9.20M | 162.86% |
| Dec 31, 2018 | 3.50M | -73.48% |
| Dec 29, 2017 | 13.20M | -52.52% |
| Dec 30, 2016 | 27.80M | 167.31% |
| Dec 31, 2015 | 10.40M | -68.86% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.81B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.44B |
| AbbVie | 313.20B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |